Nataxazole, a new benzoxazole derivative with antitumor activity produced by streptomyces sp. Tü 6176

Journal of Antibiotics

Volumn 61, Issue 11, 2008, Pages 683-686

  Sommer, Patricia S M ^b   Almeida, Rosemary C ^b   Schneider, Kathrin ^d   Beil, Winfried ^c   Süssmuth, Roderich D ^d   Fiedler, Hans Peter ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Antitumor activity; Benzoxazole derivative; HPLC diode array screening; Streptomyces; Structure elucidation

Indexed keywords

AJI 9561; ANTINEOPLASTIC AGENT; BENZOXAZOLE DERIVATIVE; NATAXAZOLE; UK 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL CYCLE PHASE; CELL STRAIN HEPG2; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG ISOLATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STREPTOMYCES;

ANTINEOPLASTIC AGENTS; BENZOXAZOLES; CELL LINE, TUMOR; HUMANS; MOLECULAR STRUCTURE; STREPTOMYCES;

STREPTOMYCES; STREPTOMYCES SP.;

EID: 58849086263     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2008.97     Document Type: Article

References (9)

1. Fiedler H-P, Dieter A, Gulder TAM, Kajahn I, Hamm A, Brown R, Jones AL, Goodfellow M, Müller WEG, Bringmann G. Genoketides Al and A2, new octaketides and biosynthetic intermediates of chrysophanol produced by Streptomyces sp. AK 671. J Antibiot 61: 464-473 (2008)
2. Fiedler H-P. Biosynthetic capacities of actinomycetes. 1. Screening for secondary metabolites by HPLC and UV-Visible absorbance spectral libraries. Nat Prod Lett 2: 119-128 (1993)
3. Staneck JL, Roberts GD. Simplified approach to the identification of aerobic actinomycetes by thin layer chromatography. Appl Microbiol 28: 226-231 (1974)
4. AL. In Bergey's Manual of Systematic Bacteriology, Vol. 4. Ed., Williams ST et al., pp. 2452-2492, Williams & Wilkins, Baltimore (1989)
5. Ueki M, Shibata K, Taniguchi M. UK-1, a novel cytotoxic metabolite from Streptomyces sp. 517-02. IV. Antifungal action of methyl UK-1. J Antibiot 46: 1089-1094 (1998)
6. Sato S, Kajiura T, Noguchi M, Takehana K, Kobayashi T, Tsuji T. AJI9561, a new cytotoxic benzoxazole derivative produced by Streptomyces sp. J Antibiot 54: 102-104 (2001)
7. Grever MR, Shepartz SA, Chabner BA. The National Cancer Institute: cancer drug discovery and development program. Semin Oncol 19: 622-638 (1992)
8. Reynolds MB, DeLuca MR, Kerwin SM. The novel bis(benzoxazole) cytotoxic natural product UK-1 is a magnesium ion-dependent DNA binding agent and inhibitor of human topoisomerase II. Bioorg Chem 27: 326-337 (1999)
9. Kaufmann WK. Human topoisomerase II function, tyrosine phosphorylation and cell cycle checkpoints. Proc Soc Exp Biol Med 217: 327-334 (1998)